Bayer to unveil new data from its phase III OASIS 3 long-term study of elinzanetant to treat vasomotor symptoms associated with menopause: Berlin Friday, September 6, 2024, 11:00 ...
Britain takes decisive action to ban 'zombie drug' xylazine and 21 other dangerous drugs: United Kingdom Friday, September 6, 2024, 10:00 Hrs [IST] Legislation has been laid in Pa ...
Abbott Park, Illinois Friday, September 6, 2024, 09:00 Hrs [IST] ...
Nandita Vijayasimha, Bengaluru Friday, September 6, 2024, 08:00 Hrs [IST] ...
Peethaambaran Kunnathoor, Chennai Friday, September 6, 2024, 08:00 Hrs [IST] ...
Shardul Nautiyal, Mumbai Friday, September 6, 2024, 08:00 Hrs [IST] ...
Health ministry adds primary hyperoxaluria under NPRD to offer financial assistance: Our Bureau, New Delhi Friday, September 6, 2024, 08:00 Hrs [IST] The Union ministry of health ...
PLI scheme for bulk drugs reports investment of Rs. 287 crore in July: Gireesh Babu, New Delhi Friday, September 6, 2024, 08:00 Hrs [IST] The production linked incentive (PLI) sch ...
Acepodia inks clinical collaboration with Pfizer to accelerate development of ACC-based cell therapies in autoimmune diseases: Alameda, California Thursday, September 5, 2024, 18: ...
Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging ...
Roche to present positive phase II FENopta OLE study data of BTK inhibitor, fenebrutinib to treat relapsing MS at 40th Congress of ECTRIMS: Basel Thursday, September 5, 2024, 13:0 ...
Hong Kong Baptist University gets China NMPA nod to begin trial with Chinese herbal formulation for ulcerative colitis: Hong Kong Thursday, September 5, 2024, 17:00 Hrs [IST] The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results